XTLB

XTL Biopharmaceuticals
XTLB

6 hedge funds and large institutions have $2.13M invested in XTL Biopharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$56K
2
+$13K

Top Sellers

1
-$65.6K
2
-$47K
3
-$10.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$871K
2
$871K
3
$226K
4
$98K
5
$56K
6
$13K
7
–